Breast Cancer Clinical Trial

Clinical Trial Finder Breast Cancer Trials

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

See Locations Near You

Summary

Study of NGM831 as Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumors

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Histologically or cytologically documented locally advanced or metastatic solid tumor malignancy.
Adequate bone marrow, kidney and liver function
Performance status of 0 or 1.
Resolved acute effects of any prior therapy to baseline severity or CTCAE Grade 1 except for AEs not constituting a safety risk by Investigator judgement.

Exclusion Criteria:

Prior treatment targeting ILT3.
Prior treatment targeting LAIR1.

Study is for people with:

Breast Cancer

Phase:

Phase 1

Estimated Enrollment:

130

Study ID:

NCT05215574

Recruitment Status:

Recruiting

Sponsor:

NGM Biopharmaceuticals, Inc

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 9 Locations for this study

See Locations Near You

NGM Clinical Study Site
Gilbert Arizona, 85234, United States More Info
NGM Site 021
Contact
NGM Clinical Study Site
Los Angeles California, 90025, United States More Info
NGM Site 022
Contact
NGM Clinical Study Site
Sarasota Florida, 34232, United States More Info
NGM Site 009
Contact
NGM Clinical Study Site
Tampa Florida, 33612, United States More Info
NGM Site 024
Contact
NGM Clinical Study Site
Grand Rapids Michigan, 49546, United States More Info
NGM Site 003
Contact
NGM Clinical Study Site
New York New York, 10016, United States More Info
NGM Site 023
Contact
NGM Clinical Study Site
Oklahoma City Oklahoma, 73104, United States More Info
NGM Site 025
Contact
NGM Clinical Study Site
Austin Texas, 78758, United States
NGM Clinical Study Site
Houston Texas, 77030, United States More Info
NGM Site 001
Contact
Load More

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 1

Estimated Enrollment:

130

Study ID:

NCT05215574

Recruitment Status:

Recruiting

Sponsor:


NGM Biopharmaceuticals, Inc

How clear is this clinincal trial information?

Clinical Trial Resources

SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials for Breast Cancer
Have You Been Diagnosed With Late-Stage Breast Cancer? Know That You Have Treatment Options.
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider